Quick-Med Technologies' Research & Development Center Moves to New Location
Posted on: Tuesday, 12 February 2008, 09:00 CST
Quick-Med Technologies (OTCBB:QMDT) announced today that its Research & Development Center has moved to a new location in Gainesville, Florida. The new space, for which it has a 3-year lease, will offer larger on-site testing facilities to better service the needs of its customers and partners.
Announcing the move, Quick-Med Technologies' Vice President of R&D and Commercialization, Dr. Gerald M. Olderman, commented: "The new larger facility is close to the University of Florida, a working partner in the company's two core technologies, and will provide us with an excellent base to service both our current and planned future growth. We look forward to a faster pace of R&D now that we have the appropriate space."
Located in close proximity to downtown and its licensor, the University of Florida at Gainesville, the Research & Development Center has settled nicely into its new surroundings. The new address and phone number are as follows:
Quick-Med Technologies, Inc
Research & Development Center
904 NW 4th Street
Gainesville, Florida 32601-4285
Tel. (352) 379.0611
Fax (352) 379.1099
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing broad-based technologies for the healthcare and consumer markets. The Company's two core product groups under development are (1) NIMBUS®, a technology employing advanced polymers that can be used in a wide range of applications from advanced wound care to industrial and consumer products; and (2) MultiStat™ family of advanced patented methods and compounds, shown to be effective in key skin care therapy applications for cosmetic, military, and medical markets. For more information, see: www.quickmedtech.com.
© 2008 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and MultiStat™ are trademarks of Quick-Med Technologies, Inc. All other trademarks are the property of their respective owners.
Safe Harbor for Forward-Looking Statements
Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and Quick-Med Technologies, Inc. intends that such forward looking statements be subject to the safe harbor created thereby. Quick-Med Technologies, Inc. does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source: Business Wire
Related Articles
- Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
- Development and Research Report on Competitive Pattern of China's Industrial Gas Market From 2008 to 2010 Available Now
- AmberWave Systems and University of New Hampshire Receive Technology Innovation Grant From the New Hampshire Innovation Research Center
- BioQuest Technologies Assists Several Wrestling Programs in South Florida High Schools Generating Great Success Inhibiting Skin Infections With BioShield 75 Antimicrobial Technology
- Hitachi Chemical Co., Ltd. Acquires Access to Future SPD-Smart Light-Control Technology Developed By Research Frontiers
- AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
- Emisphere to Receive Milestone Payment for Eligen(R) Technology to Be Used in New Development Program
- Key Technological Advancements Drive Missile and Munitions Development
- RedTail Solutions Participates in University of Florida Research Center RFID Pilot to Improve Fresh Produce Supply Chain
- Accelerated Technology's Nucleus RTOS and code|lab Developer Suite will Ship in New Intel IQ80315 Evaluation Kit
 |
 |
User Comments (0)
RSS Feeds